Cystotech Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.88M
- Investors
-
7
Cystotech General Information
Description
Developer of an artificial intelligence-based support technology designed to transform the future of bladder cancer treatment. The company's technology focuses is on changing clinical practice, favoring patient outcomes and driving healthcare toward improved personalised treatment, enabling healthcare professionals and organizations to focus on diagnostic performance and the use of less invasive approaches to treatment for the benefit of patients and healthcare costs.
Contact Information
Website
www.cystotech.comCorporate Office
- Inge Lehmanns Gade 10
- 5. sal
- 8000 Aarhus Centrum
- Denmark
Corporate Office
- Inge Lehmanns Gade 10
- 5. sal
- 8000 Aarhus Centrum
- Denmark
Cystotech Timeline
Cystotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 15-Jan-2026 | $1.88M | Completed | Startup | ||
| 8. Accelerator/Incubator | 12-Jan-2026 | Completed | Startup | |||
| 7. Early Stage VC | 05-May-2025 | Completed | Startup | |||
| 6. Accelerator/Incubator | 01-Jan-2025 | Completed | Startup | |||
| 5. Early Stage VC | 21-Aug-2024 | Completed | Startup | |||
| 4. Seed Round | 01-Aug-2023 | Completed | Startup | |||
| 3. Seed Round | 27-Jun-2022 | Completed | Startup | |||
| 2. Seed Round | 01-May-2022 | $138K | $138K | Completed | Startup | |
| 1. University Spin-Out | 20-Oct-2021 | Completed | Startup |
Cystotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 4,560 | $130.73 | $130.73 | 1x | $130.73 | 6.51% | ||
| Ordinary | 3,040 | $49.02 | $49.02 | 1x | $49.02 | 4.34% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cystotech Signals
Cystotech Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Delphinus Venture Capital | Venture Capital | Minority | ||
| CancerX (USA) | Accelerator/Incubator | |||
| INCUBA | Accelerator/Incubator | Minority | ||
| InnoFounder | Accelerator/Incubator | Minority | ||
| Danish Business Angels | Angel Group | Minority |
Cystotech FAQs
-
When was Cystotech founded?
Cystotech was founded in 2021.
-
Where is Cystotech headquartered?
Cystotech is headquartered in Aarhus Centrum, Denmark.
-
What is the size of Cystotech?
Cystotech has 12 total employees.
-
What industry is Cystotech in?
Cystotech’s primary industry is Diagnostic Equipment.
-
Is Cystotech a private or public company?
Cystotech is a Private company.
-
What is the current valuation of Cystotech?
The current valuation of Cystotech is .
-
What is Cystotech’s current revenue?
The current revenue for Cystotech is .
-
How much funding has Cystotech raised over time?
Cystotech has raised $5.49M.
-
Who are Cystotech’s investors?
Delphinus Venture Capital, CancerX (USA), INCUBA, InnoFounder, and Danish Business Angels are 5 of 7 investors who have invested in Cystotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process